drugset / Trial / NCT03953326
HeartPhone Cancer Survivors Trial 2019
NaSingle-groupOpen-labelPrevention
Summary
This is a behavioral study that will examine changes in physical activity and vascular health in response to a digital tool (app) that will appear on participant's lock screen of their Android phone. Participants will be asked to use this app for 3 months and to wear a Fitbit device continuously throughout the study. Participants will be asked to complete questionnaires, participate in fitness testing and measures of cardiovascular health at 3 months and 6 months after baseline assessments. The hypothesis is that exposure to the app will lead to increased physical activity volume and improved microvessel function.
Timeline
- Start
- 2019-04-23
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetylcholine | Small molecule | — | — |
| Subject | METHYL P-TOLUENESULFONYL-L-ARGININATE | Small molecule | — | — |
| Subject | Sodium Nitroprusside | Unknown | — | — |